Innocrin Pharmaceutical   Report issue

For profit Phase 2
Founded: Durham NC United States (2004)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2011
NCT02012920
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

seviteronel (5 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Breast Neoplasms, Male (Phase 2)

Prostatic Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 1